OR WAIT null SECS
Making the Grade: The Importance of Using the Correct Excipient Grade in Drug Products
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
Activation and expansion are essential for success in both autologous and allogeneic therapies.
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
This article explores the emergence of subjectivity in ICH Q9 (R1).
The Biosimilars Landscape
March 29, 2024
Dr. Reddy’s has gained exclusive rights to promote and distribute Sanofi’s vaccines in India.
FDA has approved AstraZeneca's Ultomiris, marking the first and only long-acting C5 complement inhibitor for patients with NMOSD.
March 28, 2024
Univercells and Altamira Therapeutics are collaborating on nanoparticle-delivered mRNA vaccines, while Andelyn Biosciences and Grace Science are partnering on novel therapies for NGLY1 deficiency.
March 27, 2024
Drs Dawn Dufield and Dominic Warrino, KCAS Bioanalytical and Biomarker Services, share expertise on using Hybrid LC-MS versus LBA for bioanalytical analysis.
March 26, 2024
The Vacaville, Calif., site acquisition gives Lonza one of the largest biologics manufacturing sites for mammalian cell-based therapies worldwide.
In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
March 22, 2024
The company is recalling one lot of the product because of the potential presence of silicone particulates.
AstraZeneca’s acquisition of Amolyt Pharma includes eneboparatide, a Phase III therapeutic peptide for the treatment of hypoparathyroidism.
CDMO White Raven aims to reduce contamination risk and gain the capability to handle multiple product formats with the installation of Cytiva’s SA25 Aseptic Filling Workcell.
March 21, 2024
The conference intends to help attendees streamline their manufacturing and distribution procedures to improve patient outcomes.